|
|
5S C Bischoff
![]() Summary for 2004 [at-glance overview of S C Bischoff work for the selected year as suggested by data mining algorithms]This is an Authoratory overview of author S C Bischoff. According to available data, in 2004 S C Bischoff published at least 5 articles. This work was completed in collaboration with several authors including Levi-Schaffer, F and Schölmerich, J. Many other authors have collaborated with S C Bischoff as well. There is no information about the funding or the grants awarded to support this work.
S C Bischoff has rank 72 when compared to all other authors using the keyword Colitis, Ulcerative. Analysis of the article abstracts and the titles suggests that S C Bischoff professional interests are focused around "intestinal mast cells", "human intestinal mast" and "mast cells eosinophils". These might also be referred to as "mast cells", "human intestinal" or "mediator release". Statistical analysis shows that S C Bischoff's writing is likely to contains terms "mast", "cells", "intestinal", "disease", "release" and "collagen".
Unfortunately, there is not enough information to establish S C Bischoff affiliation. Luckily, several email addresses are on file. Images [images we found on the Internet for S C Bischoff]loading...
Do you know S C Bischoff who matches the profile above? Click the photo and let us know!
Alternative names (1) [other authors with names similar to S C Bischoff]Year 2004 Charts [S C Bischoff frequent coauthors and the most common unique vocabulary terms for the selected year]Historical Performance Charts [graphical overview of S C Bischoff publication and funding history for the range of years]Emails (2) [email addresses extracted from S C Bischoff affiliations]hidden to prevent spam, click here to reveal S C Bischoff Coauthors (37) [all coauthors with the number of joint publications] Other [context-specific ads]Affiliations (5) [condensed summary of the S C Bischoff affiliations, the leading number and the color conveys importance]- 1Martin-Luther-Universität Halle-Wittenberg, Klinik und Poliklinik für Innere Medizin I, Halle.
1Medizinische Hochschule Hannover, Abt. Gastroenterologie, Hepatologie und Endokrinologie, Hannover. 1Medizinische Klinik I mit Schwerpunkt Gastroenterologie/Infektiologie/Rheumatologie, Charité, Universitätsmedizin Berlin. 1Dept. of Pharmacology, School of Pharmacy, David R. Bloom Center for Pharmacy, The Hebrew University of Jerusalem, Israel. 1Department of Gastroenterology, Hepatology and Endocrinology, Medical School of Hannover, Hannover, Germany.
Key Opinion Leader In [S C Bischoff is considered a key opinion leader in any keyword where the rank of 5 is achieved, the leading number before the keyword shows the author's rank as compared to all other authors]Keywords (32) [keywords assigned to S C Bischoff articles by PubMed, the leading number and the color conveys importance]- 5Humans | 3Colitis, Ulcerative | 2Adolescent | 2Child | 2Mast Cells | 2Recurrence | 2Randomized Controlled Trials as Topic | 2Adult | 2Female | 2Male | 2Remission Induction | 1Vitamins | 1Colon | 1Intestines | 1Follow-Up Studies | 1Eosinophils | 1Nutritional Physiological Phenomena | 1Fibrosis | 1Tumor Necrosis Factor-alpha | 1Immunosuppressive Agents | 1Dietary Supplements | 1Cell Division | 1Azathioprine | 1Cell Communication | 1Reverse Transcriptase Polymerase Chain Reaction | 1Minerals | 1Colectomy | 1Substance P | 1Mesalamine | 1Crohn Disease | 1Administration, Oral | 1Adrenal Cortex Hormones
S C Bischoff Unique Vocabulary (96) [single words, word pairs and phrases obtained by analysis of abstracts and titles, the leading number and the color conveys importance; S C Bischoff might be a good expert witness on these terms]- 13mast | 11cells | 7intestinal | 6disease | 6release | 6collagen | 5human | 5sp | 5mediator | 5crohn | 4neuropeptides | 4peptides | 4fibroblast | 3mediators | 3show | 3induce | 3isolated | 3colitis | 3ulcerative | 3eosinophils | 3sonicates | 3substance | 3data | 3production | 2act | 2profibrogenic | 2receptor-crosslinking | 2potential | 2decreased | 2positive | 2ige | 2role
- 11mast cells | 5human intestinal | 5mediator release | 5intestinal mast | 5crohn disease | 3collagen production | 3cells eosinophils | 3ulcerative colitis | 3gel contraction | 3fibroblast proliferation | 2data show | 2potential profibrogenic | 2induce mediator | 2substance neuropeptides | 2ige receptor-crosslinking | 2profibrogenic role | 2neuropeptides induce | 2eosinophils potential | 2release isolated | 2role crohn | 2isolated human | 2decreased collagen | 2mast cell | 2sonicates increased | 2collagen gel | 2colitis results | 1derived crohn | 1digestive metabolic | 1tachykinin receptors | 1collagen synthesis | 185-99 purity | 1influence found
- 5intestinal mast cells | 5human intestinal mast | 3mast cells eosinophils | 2eosinophils potential profibrogenic | 2neuropeptides induce mediator | 2release isolated human | 2profibrogenic role crohn | 2mediator release isolated | 2isolated human intestinal | 2role crohn disease | 2decreased collagen production | 2potential profibrogenic role | 2induce mediator release | 2cells eosinophils potential | 2substance neuropeptides induce | 2collagen gel contraction | 2ulcerative colitis results | 1pre-activated ige receptor-crosslinking | 1collagen production increased | 1vitro data show | 1based consensus conference | 1results evidence based | 1reverse transcriptase-polymerase chain | 1obtained mostly rodent | 1mast cells express | 1agonists thus mediators | 1secretagogues human intestinal | 1sp related peptides | 1detected cases sonicates | 1peptides mediator release | 1failed cause mediator | 1unpurified enriched 85-99
Reader's Comments (0) [comments posted by readers of S C Bischoff profile]Funding (0) [selected NIH grants to S C Bischoff and the award amounts for recent years]- award information is not available
S C Bischoff Articles (5) [selected PubMed articles for the year 2004 with the links to a full text at PubMed][Ulcerative colitis. Acute episode] (2004) >> Martin-Luther-Universität Halle-Wittenberg, Klinik und Poliklinik für Innere Medizin I, Halle. 3Reissmann, A, 5Bischoff, S C, 4Fleig, W.[Ulcerative colitis. Nutrition] (2004) >> Medizinische Hochschule Hannover, Abt. Gastroenterologie, Hepatologie und Endokrinologie, Hannover. 5Bischoff, S C, 4Fleig, W.[Diagnosis and therapy of ulcerative colitis: results of an evidence based consensus conference by the German society of Digestive and Metabolic Diseases and the competence network on inflammatory bowel disease] (2004) >> Medizinische Klinik I mit Schwerpunkt Gastroenterologie/Infektiologie/Rheumatologie, Charité, Universitätsmedizin Berlin. 7Wittekind, C, 1Riemann, J, 5Bischoff, S C, 4Pox, C, 1Kroesen, A J, 5Hoffmann, J C, 8Schwandner, O, 9Schmiegel, W, 6Reinshagen, M, 11Fölsch, U R, 1Kaltz, B, 2Selbmann, H K, 5Buhr, H J, 6Moser, G, 4Fleig, W, 5Herrlinger, K, 2Knebel, U, 17Zeitz, M, 6Kruis, W, 9Rogler, G, 1Keller, K M, 6Fischer, I, 3Jantschek, G, 33Schölmerich, J, 2Brambs, H J, 7Stange, E F, 4Dignass, A, 2Höhne, W, 1Mundt, S, 3Reissmann, A, 14Schreiber, S, 3Matthes, H, 4Bruch, H P, 2Utzig, M.Mast cells and eosinophils have a potential profibrogenic role in Crohn disease. (2004) >> Dept. of Pharmacology, School of Pharmacy, David R. Bloom Center for Pharmacy, The Hebrew University of Jerusalem, Israel. 3Pappo, O, 5Bischoff, S C, 3Levi-Schaffer, F, 1Rivkind, A, 1Pikarsky, A, 13Xu, X.Substance P and other neuropeptides do not induce mediator release in isolated human intestinal mast cells. (2004) >> Department of Gastroenterology, Hepatology and Endocrinology, Medical School of Hannover, Hannover, Germany. 1Bektas, H, 4Sann, H, 29Manns, M P, 5Schemann, M, 5Bischoff, S C, 3Levi-Schaffer, F, 1Schwengberg, S, 3Shanahan, F, 1Lorentz, A.
Science Trivia (2) [Interactive math & science trivia questions]
|
|